Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hester A de Groot-Kruseman

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Pediatric Blood & Cancer|October 14, 2021
Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemiaAnnelien L van Binsbergen, Valérie de Haas, Vincent H J van der Velden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2020
Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic LeukemiaRobin Q H Kloos, Rob Pieters, Florine M V Jumelet, et al.
Haematologica|August 24, 2014
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemiaWing H Tong, Rob Pieters, Hester A de Groot-Kruseman, et al.
Blood|February 23, 2024
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domainInge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, et al.
Leukemia|August 22, 2020
Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015Ardine M J Reedijk, Jan Willem W Coebergh, Hester A de Groot-Kruseman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2003
Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal studyHester A de Groot-Kruseman, Wendy M Mol, Hubert G M Niesters, et al.
Leukemia|August 29, 2020
Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphologyValérie de Haas, Rob Pieters, Alita J van der Sluijs-Gelling, et al.
Hemasphere|December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma CohortEmma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Clinical Transplantation|November 20, 2002
Sequential monitoring of intragraft cytokine mRNA expression in relation to diastolic left ventricular wall thickness and function early after heart transplantationHester A de Groot-Kruseman, Carla C Baan, Elly M Hagman, et al.
Scientific Reports|March 16, 2019
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Judith M Boer, Alex Q Hoogkamer, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|October 14, 2021
Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemiaAnnelien L van Binsbergen, Valérie de Haas, Vincent H J van der Velden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2020
Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic LeukemiaRobin Q H Kloos, Rob Pieters, Florine M V Jumelet, et al.
Haematologica|August 24, 2014
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemiaWing H Tong, Rob Pieters, Hester A de Groot-Kruseman, et al.
Blood|February 23, 2024
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domainInge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, et al.
Leukemia|August 22, 2020
Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015Ardine M J Reedijk, Jan Willem W Coebergh, Hester A de Groot-Kruseman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2003
Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal studyHester A de Groot-Kruseman, Wendy M Mol, Hubert G M Niesters, et al.
Leukemia|August 29, 2020
Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphologyValérie de Haas, Rob Pieters, Alita J van der Sluijs-Gelling, et al.
Hemasphere|December 29, 2021
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma CohortEmma Kroeze, Dilys D Weijers, Melanie M Hagleitner, et al.
Clinical Transplantation|November 20, 2002
Sequential monitoring of intragraft cytokine mRNA expression in relation to diastolic left ventricular wall thickness and function early after heart transplantationHester A de Groot-Kruseman, Carla C Baan, Elly M Hagman, et al.
Scientific Reports|March 16, 2019
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Judith M Boer, Alex Q Hoogkamer, et al.
Pageof 4